Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 2475631, 14 pages
http://dx.doi.org/10.1155/2016/2475631
Research Article

High Content Analysis of Human Pluripotent Stem Cell Derived Hepatocytes Reveals Drug Induced Steatosis and Phospholipidosis

1Takara Bio Europe AB (Former Cellectis AB/Cellartis AB), Arvid Wallgrens Backe 20, 413 46 Göteborg, Sweden
2Novo Nordisk A/S, Stem Cell Development, 2880 Bagsværd, Denmark
3Horizon Discovery Ltd, 7100 Cambridge Research Park, Waterbeach, Cambridge CB25 9TL, UK
4Systems Biology Research Center, School of Bioscience, University of Skövde, 541 28 Skövde, Sweden
5Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, 171 77 Stockholm, Sweden
6AstraZeneca R&D, GMD CVMD GMed, 431 83 Mölndal, Sweden
7NovaHep AB, Arvid Wallgrens Backe 20, 413 46 Göteborg, Sweden

Received 30 July 2015; Revised 7 October 2015; Accepted 13 October 2015

Academic Editor: Toon van Veen

Copyright © 2016 Arvind Pradip et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [17 citations]

The following is the list of published articles that have cited the current article.

  • Robert P. Jones, Mohamed Elmasry, Richard J. Weaver, Philip G. Hewitt, Magnus Ingelman-Sundberg, Chris E. Goldring, B. Kevin Park, Rowena L. Sison-Young, Volker M. Lauschke, Esther Johann, Eliane Alexandre, Sébastien Antherieu, Hélène Aerts, Helga H. J. Gerets, Gilles Labbe, Delphine Hoët, Martina Dorau, Christopher A. Schofield, Cerys A. Lovatt, Julie C. Holder, Simone H. Stahl, Lysiane Richert, and Neil R. Kitteringham, “A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicity,” Archives of Toxicology, 2016. View at Publisher · View at Google Scholar
  • Maria Teresa Donato, Maria José Gómez-Lechón, and Laia Tolosa, “Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies,” Expert Opinion on Drug Discovery, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Mikael Persson, and Jorrit J. Hornberg, “Advances in Predictive Toxicology for Discovery Safety through High Content Screening,” Chemical Research in Toxicology, 2016. View at Publisher · View at Google Scholar
  • Z. Li, M.E. Cvijic, and L. Zhang, “Cellular Imaging in Drug Discovery,” Reference Module in Chemistry, Molecular Sciences and Chemical Engineering, 2016. View at Publisher · View at Google Scholar
  • Christine Lin, and Salman R. Khetani, “Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury,” BioMed Research International, vol. 2016, pp. 1–20, 2016. View at Publisher · View at Google Scholar
  • Shuai Ge, Li-Jie Fu, Na-Ping Tang, and Jing Ma, “High-content screening in studies of toxicology and its application in drug-induced hepatotoxicity,” Chinese Journal of Pharmacology and Toxicology, vol. 31, no. 6, pp. 689–695, 2017. View at Publisher · View at Google Scholar
  • Volker M. Lauschke, Henrik Palmgren, Rodger Duffin, Magnus Ingelman-Sundberg, Catherine C. Bell, Sabine U. Vorrink, and Tommy B. Andersson, “Transcriptional, functional, and mechanistic comparisons of stem cell-derived hepatocytes, HepaRG cells, and three-dimensional human hepatocyte spheroids as predictive in vitro systems for drug-induced liver injury,” Drug Metabolism and Disposition, vol. 45, no. 4, pp. 419–429, 2017. View at Publisher · View at Google Scholar
  • Peter James O’Brien, and Anna Edvardsson, “Validation of a Multiparametric, High-Content-Screening Assay for Predictive/Investigative Cytotoxicity: Evidence from Technology Transfer Studies and Literature Review,” Chemical Research in Toxicology, 2017. View at Publisher · View at Google Scholar
  • Jose Meseguer-Ripolles, Salman R. Khetani, Javier G. Blanco, Miari Iredale, and David C. Hay, “Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety,” The AAPS Journal, vol. 20, no. 1, 2017. View at Publisher · View at Google Scholar
  • Sandra Pisonero-Vaquero, and Diego Luis Medina, “Lysosomotropic drugs: Pharmacological tools to study lysosomal function,” Current Drug Metabolism, vol. 18, no. 12, pp. 1147–1158, 2017. View at Publisher · View at Google Scholar
  • Xinglei Yao, Nuoya Yin, and Francesco Faiola, “Stem cell toxicology: A powerful tool to assess pollution effects on human health,” National Science Review, vol. 3, no. 4, pp. 430–450, 2017. View at Publisher · View at Google Scholar
  • Sakil Kulkarni, and David A. Rudnick, “Induced Pluripotent Stem Cell-Derived Hepatocytes and Precision Medicine in Human Liver Disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 66, no. 5, pp. 716–719, 2018. View at Publisher · View at Google Scholar
  • Alexander David Roth, Pratap Lama, Stephen Dunn, Stephen Hong, and Moo-Yeal Lee, “Polymer coating on a micropillar chip for robust attachment of PuraMatrix peptide hydrogel for 3D hepatic cell culture,” Materials Science and Engineering: C, 2018. View at Publisher · View at Google Scholar
  • Xihui Zhang, Liecheng Yang, Yongming Liu, Zhentao Song, Jian Zhao, Dandan Chen, Huan Yu, Ruibin Li, Yangyun Wang, Kai Yang, Yu Chen, Menghang Xia, and Leshuai W. Zhang, “Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis,” Toxicology and Applied Pharmacology, 2018. View at Publisher · View at Google Scholar
  • Mathieu Vinken, “In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist,” Archives of Toxicology, 2018. View at Publisher · View at Google Scholar
  • Mikael Persson, “High Content Screening for Prediction of Human Drug-Induced Liver Injury,” Drug-Induced Liver Toxicity, pp. 331–343, 2018. View at Publisher · View at Google Scholar
  • Vânia Vilas-Boas, Axelle Cooreman, Eva Gijbels, Raf Van Campenhout, Emma Gustafson, Steven Ballet, Pieter Annaert, Bruno Cogliati, and Mathieu Vinken, “Primary Hepatocytes and Their Cultures for the Testing of Drug-Induced Liver Injury,” 2018. View at Publisher · View at Google Scholar